{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:55:34Z","timestamp":1789408534747,"version":"build-2803163510"},"reference-count":140,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1093\/jrr\/rrt227","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T02:19:27Z","timestamp":1392257967000},"page":"613-628","source":"Crossref","is-referenced-by-count":28,"title":["Chromatin-regulating proteins as targets for cancer therapy"],"prefix":"10.1093","volume":"55","author":[{"given":"Takahiro","family":"Oike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Ogiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Napapat","family":"Amornwichet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,2,11]]},"reference":[{"key":"key\n\t\t\t\t20170511060840_RRT227C1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.biochem.77.062706.153223","article-title":"The biology of chromatin remodeling complexes","volume":"78","author":"Clapier","year":"2009","journal-title":"Annu Rev Biochem"},{"key":"key\n\t\t\t\t20170511060840_RRT227C2","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1158\/1078-0432.CCR-10-0513","article-title":"Epigenetic modifications in double-strand break DNA damage signaling and repair","volume":"15","author":"Rossetto","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170511060840_RRT227C3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-9525(03)00115-X","article-title":"The diverse functions of histone acetyltransferase complexes","volume":"19","author":"Carrozza","year":"2003","journal-title":"Trends Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C4","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/onc.2010.592","article-title":"Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI\/SNF chromatin remodeling and the recruitment of non-homologous end joining factors","volume":"5","author":"Ogiwara","year":"2011","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170511060840_RRT227C5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/ncb1343","article-title":"Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks","volume":"8","author":"Murr","year":"2006","journal-title":"Nat Cell Biol"},{"key":"key\n\t\t\t\t20170511060840_RRT227C6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nature01035","article-title":"Acetylation of histone H4 by Esa1 is required for DNA double-strand break repair","volume":"419","author":"Bird","year":"2002","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511060840_RRT227C7","doi-asserted-by":"crossref","first-page":"e52810","DOI":"10.1371\/journal.pone.0052810","article-title":"CBP and p300 histone acetyltransferases contribute to homologous recombination by transcriptionally activating the BRCA1 and RAD51 genes","volume":"7","author":"Ogiwara","year":"2012","journal-title":"PLOS ONE"},{"key":"key\n\t\t\t\t20170511060840_RRT227C8","doi-asserted-by":"crossref","first-page":"51163","DOI":"10.1074\/jbc.M409024200","article-title":"Curcumin, a novel p300\/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone\/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170511060840_RRT227C9","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/j.febslet.2006.06.092","article-title":"Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation","volume":"580","author":"Sun","year":"2006","journal-title":"FEBS Lett"},{"key":"key\n\t\t\t\t20170511060840_RRT227C10","article-title":"Emerging roles of anacardic acid and its derivatives: a pharmacological overview","author":"Hemshekhar","year":"21 2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"key\n\t\t\t\t20170511060840_RRT227C11","doi-asserted-by":"crossref","first-page":"19134","DOI":"10.1074\/jbc.M301580200","article-title":"Small molecule modulators of histone acetyltransferase p300","volume":"278","author":"Balasubramanyam","year":"2003","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170511060840_RRT227C12","doi-asserted-by":"crossref","first-page":"33716","DOI":"10.1074\/jbc.M402839200","article-title":"Polyisoprenylated benzphenone, garcinol, anatural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170511060840_RRT227C13","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.ijrobp.2012.01.017","article-title":"Garcinol, a histone acetyltransferase inhibitor, radiosensitizes cancer cells by inhibiting non-homologous end joining","volume":"84","author":"Oike","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20170511060840_RRT227C14","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/carcin\/bgt240","article-title":"Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor","volume":"34","author":"Ogiwara","year":"2013","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t20170511060840_RRT227C15","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/lary.20582","article-title":"Curcumin: a potential radio-enhancer in head and neck cancer","volume":"119","author":"Khafif","year":"2009","journal-title":"Laryngoscope"},{"key":"key\n\t\t\t\t20170511060840_RRT227C16","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ijrobp.2009.06.034","article-title":"Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kB activity","volume":"75","author":"Sandur","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20170511060840_RRT227C17","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1158\/0008-5472.CAN-06-3066","article-title":"Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K\/mTOR\/ETS2 pathway","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170511060840_RRT227C18","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/sj.onc.1207284","article-title":"Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3","volume":"23","author":"Chendil","year":"2004","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170511060840_RRT227C19","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3892\/ol_00000134","article-title":"Radiosensitizing effect of the histone acetyltransferase inhibitor anacardic acid on various mammalian cell lines","volume":"1","author":"Cate","year":"2010","journal-title":"Oncol Lett"},{"key":"key\n\t\t\t\t20170511060840_RRT227C20","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1158\/1078-0432.CCR-06-2872","article-title":"Inhibition of Poly (ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models","volume":"13","author":"Albert","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170511060840_RRT227C21","first-page":"6008","article-title":"Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly (ADP-ribose) polymerase-1","volume":"63","author":"Veuger","year":"2003","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170511060840_RRT227C22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1471-4159.2007.04633.x","article-title":"Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors","volume":"102","author":"Dhandapani","year":"2007","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20170511060840_RRT227C23","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.1038\/sj.onc.1202980","article-title":"Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK\/IKK signalling complex","volume":"18","author":"Plummer","year":"1999","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170511060840_RRT227C24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1254\/jphs.12149FP","article-title":"Inhibition of the PI3K\/AKT-NF-\u03baB pathway with curcumin enhanced radiation-induced apoptosis in human Burkitt's lymphoma","volume":"121","author":"Qiao","year":"2013","journal-title":"J Pharmacol Sci"},{"key":"key\n\t\t\t\t20170511060840_RRT227C25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1756-8722-2-38","article-title":"Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs","volume":"2","author":"Padhye","year":"2009","journal-title":"J Hematol Oncol"},{"key":"key\n\t\t\t\t20170511060840_RRT227C26","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/jcb.22492","article-title":"Apoptosis-inducing effect of garcinol is mediated by NF-kappaB signaling in breast cancer cells","volume":"109","author":"Ahmad","year":"2010","journal-title":"Cell Biochem"},{"key":"key\n\t\t\t\t20170511060840_RRT227C27","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/bjc.2013.21","article-title":"Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair","volume":"108","author":"Groselj","year":"2013","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20170511060840_RRT227C28","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nsmb.1899","article-title":"Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining","volume":"17","author":"Miller","year":"2010","journal-title":"Nat Struct Mol Biol"},{"key":"key\n\t\t\t\t20170511060840_RRT227C29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijrobp.2004.12.088","article-title":"Modulation of radiation response by histone deacetylase inhibition","volume":"62","author":"Chinnaiyan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20170511060840_RRT227C30","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1158\/1541-7786.MCR-11-0587","article-title":"Suberoylanilide hydroxamic acid as a radiosensitizer through modulation of RAD51 protein and inhibition of homology-directed repair in multiple myeloma","volume":"10","author":"Chen","year":"2012","journal-title":"Mol Cancer Res"},{"key":"key\n\t\t\t\t20170511060840_RRT227C31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijrobp.2010.03.010","article-title":"Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition","volume":"78","author":"Blattmann","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20170511060840_RRT227C32","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1158\/1078-0432.CCR-04-2088","article-title":"Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity","volume":"11","author":"Munshi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170511060840_RRT227C33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/cbr.2009.0629","article-title":"HDAC inhibitor, valproic acid, induces p53\u2013dependent radiosensitization of colon cancer cells","volume":"24","author":"Chen","year":"2009","journal-title":"Cancer Biother Radiopharm"},{"key":"key\n\t\t\t\t20170511060840_RRT227C34","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.molcel.2010.12.003","article-title":"The ACF1 complex is required for DNA double-strand break repair in human cells","volume":"40","author":"Lan","year":"2010","journal-title":"Mol Cell"},{"key":"key\n\t\t\t\t20170511060840_RRT227C35","first-page":"419","article-title":"Radiosensitizers and bioreductive drugs","volume-title":"Radiobiology for the Radiologist","author":"Hall","year":"2006"},{"key":"key\n\t\t\t\t20170511060840_RRT227C36","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1158\/1078-0432.CCR-09-0096","article-title":"Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair","volume":"15","author":"Bolderson","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170511060840_RRT227C37","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/sj.bjc.6604208","article-title":"G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer","volume":"98","author":"Bucher","year":"2008","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20170511060840_RRT227C38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5772\/56555","article-title":"Histone acetyltransferases (HATs) involved in non-homologous end joining as a target for radiosensitization","volume-title":"Frontiers in Radiation Oncology","author":"Oike","year":"2013"},{"key":"key\n\t\t\t\t20170511060840_RRT227C39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1507\/endocrj.K08E-016","article-title":"Successful treatment of anaplastic thyroid carcinoma with a combination of oral valproic acid, chemotherapy, radiation and surgery","volume":"56","author":"Noguchi","year":"2009","journal-title":"Endocr J"},{"key":"key\n\t\t\t\t20170511060840_RRT227C40","first-page":"2437","article-title":"Influence of valproic acid on outcome of high-grade gliomas in children","volume":"28","author":"Masoudi","year":"2008","journal-title":"Anticancer Res"},{"key":"key\n\t\t\t\t20170511060840_RRT227C41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(10)70058-9","article-title":"Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the pelvic radiation and vorinostat (PRAVO) phase 1 study","volume":"11","author":"Ree","year":"2010","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20170511060840_RRT227C42","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1073\/pnas.1000398107","article-title":"Mechanism of chromatin remodeling","volume":"107","author":"Lorch","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170511060840_RRT227C43","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrm1945","article-title":"Chromatin remodelling: the industrial revolution of DNA around histones","volume":"7","author":"Saha","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key\n\t\t\t\t20170511060840_RRT227C44","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/hmg\/ddi091","article-title":"Transcriptional targets of the chromatin-remodelling factor SMARCA4\/BRG1 in lung cancer cells","volume":"14","author":"Medina","year":"2005","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C45","doi-asserted-by":"crossref","first-page":"11268","DOI":"10.1073\/pnas.94.21.11268","article-title":"RB and hbrm cooperate to repress the activation functions of E2F1","volume":"94","author":"Trouche","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170511060840_RRT227C46","doi-asserted-by":"crossref","first-page":"17745","DOI":"10.1073\/pnas.0509014102","article-title":"Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation","volume":"102","author":"Isakoff","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170511060840_RRT227C47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/8811","article-title":"c-MYC interacts with INI1\/hSNF5 and requires the SWI\/SNF complex for transactivation function","volume":"22","author":"Cheng","year":"1999","journal-title":"Nature Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C48","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1158\/0008-5472.CAN-08-0115","article-title":"RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5\/INI1","volume":"68","author":"Caramel","year":"2008","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170511060840_RRT227C49","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrc3068","article-title":"SWI\/SNF nucleosome remodellers and cancer","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"key\n\t\t\t\t20170511060840_RRT227C50","doi-asserted-by":"crossref","first-page":"30897","DOI":"10.1074\/jbc.R111.309302","article-title":"SWI\/SNF chromatin-remodeling factors: multiscale analyses and diverse functions","volume":"287","author":"Euskirchen","year":"2012","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170511060840_RRT227C51","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/onc.2009.4","article-title":"The SWI\/SNF complex and cancer","volume":"28","author":"Reisman","year":"2009","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170511060840_RRT227C52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cell.2009.01.009","article-title":"Understanding the words of chromatin regulation","volume":"136","author":"Wu","year":"2009","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170511060840_RRT227C53","doi-asserted-by":"crossref","first-page":"e55119","DOI":"10.1371\/journal.pone.0055119","article-title":"The spectrum of SWI\/SNF mutations, ubiquitous in human cancers","volume":"8","author":"Shain","year":"2013","journal-title":"PLOS ONE"},{"key":"key\n\t\t\t\t20170511060840_RRT227C54","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/humu.20730","article-title":"Frequent BRG1\/SMARCA4-inactivating mutations in human lung cancer cell lines","volume":"29","author":"Medina","year":"2008","journal-title":"Hum Mutat"},{"key":"key\n\t\t\t\t20170511060840_RRT227C55","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing","volume":"150","author":"Imielinski","year":"2012","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170511060840_RRT227C56","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ng.2468","article-title":"The genetic landscape of mutations in Burkitt lymphoma","volume":"44","author":"Love","year":"2012","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature11213","article-title":"Novel mutations target distinct subgroups of medulloblastoma","volume":"488","author":"Robinson","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511060840_RRT227C58","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature11329","article-title":"Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations","volume":"488","author":"Pugh","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511060840_RRT227C59","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nrneurol.2012.78","article-title":"The clinical implications of medulloblastoma subgroups","volume":"8","author":"Northcott","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"key\n\t\t\t\t20170511060840_RRT227C60","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.2591","article-title":"Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity","volume":"45","author":"Dulak","year":"2013","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C61","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1158\/0008-5472.CAN-12-4593","article-title":"A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1","volume":"73","author":"Oike","year":"2013","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170511060840_RRT227C62","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1158\/1078-0432.CCR-03-0489","article-title":"Chromatin remodeling factors and BRM\/BRG1 expression as prognostic indicators in non-small cell lung cancer","volume":"10","author":"Fukuoka","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170511060840_RRT227C63","first-page":"560","article-title":"Loss of BRG1\/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis","volume":"63","author":"Reisman","year":"2003","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170511060840_RRT227C64","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ajhg.2010.01.013","article-title":"Germline nonsense mutation and somatic inactivation of SMARCA4\/BRG1 in a family with rhabdoid tumor predisposition syndrome","volume":"86","author":"Schneppenheim","year":"2010","journal-title":"Am J Hum Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C65","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.1038\/sj.onc.1210514","article-title":"The reversible epigenetic silencing of BRM: implications for clinical targeted therapy","volume":"26","author":"Glaros","year":"2007","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170511060840_RRT227C66","doi-asserted-by":"crossref","first-page":"10727","DOI":"10.1158\/0008-5472.CAN-07-2601","article-title":"Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state","volume":"67","author":"Yamamichi","year":"2007","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170511060840_RRT227C67","doi-asserted-by":"crossref","first-page":"10154","DOI":"10.1158\/0008-5472.CAN-08-1794","article-title":"The SWI\/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer","volume":"68","author":"Shen","year":"2008","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170511060840_RRT227C68","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/28212","article-title":"Truncating mutations of hSNF5\/INI1 in aggressive paediatric cancer","volume":"394","author":"Versteege","year":"1998","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511060840_RRT227C69","first-page":"74","article-title":"Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors","volume":"59","author":"Biegel","year":"1999","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170511060840_RRT227C70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10048-011-0300-y","article-title":"Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri","volume":"13","author":"van den Munckhof","year":"2012","journal-title":"Neurogenetics"},{"key":"key\n\t\t\t\t20170511060840_RRT227C71","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jmg.2010.082420","article-title":"Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas","volume":"48","author":"Christiaans","year":"2011","journal-title":"J Med Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C72","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/513207","article-title":"Germline mutation of INI1\/SMARCB1 in familial schwannomatosis","volume":"80","author":"Hulsebos","year":"2007","journal-title":"Am J Hum Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C73","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/ng0894-480","article-title":"Cooperative tumorigenic effects of germline mutations in Rb and p53","volume":"7","author":"Williams","year":"1994","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3835(00)00342-6","article-title":"Absence of hSNF5\/INI1 mutation in human lung cancer","volume":"153","author":"Manda","year":"2000","journal-title":"Cancer Lett"},{"key":"key\n\t\t\t\t20170511060840_RRT227C75","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1196333","article-title":"Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma","volume":"330","author":"Jones","year":"2010","journal-title":"Science"},{"key":"key\n\t\t\t\t20170511060840_RRT227C76","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170511060840_RRT227C77","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature09639","article-title":"Exome sequencing identifies frequent mutation of the SWI\/SNF complex gene PBRM1 in renal carcinoma","volume":"469","author":"Varela","year":"2011","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511060840_RRT227C78","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ng.2291","article-title":"Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators","volume":"44","author":"Fujimoto","year":"2012","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C79","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ng.907","article-title":"Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder","volume":"43","author":"Gui","year":"2011","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C80","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/ng.2246","article-title":"Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes","volume":"44","author":"Zang","year":"2012","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C81","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng.2455","article-title":"Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes","volume":"44","author":"Le Gallo","year":"2012","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C82","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/ng.2493","article-title":"Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma","volume":"45","author":"Sausen","year":"2013","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C83","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature11547","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","author":"Biankin","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511060840_RRT227C84","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170511060840_RRT227C85","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1126\/science.1198056","article-title":"The genetic landscape of the childhood cancer medulloblastoma","volume":"331","author":"Parsons","year":"2011","journal-title":"Science"},{"key":"key\n\t\t\t\t20170511060840_RRT227C86","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature11017","article-title":"The landscape of cancer genes and mutational processes in breast cancer","volume":"486","author":"Stephens","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511060840_RRT227C87","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/ng.903","article-title":"Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma","volume":"43","author":"Li","year":"2011","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C88","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1158\/0008-5472.CAN-07-5276","article-title":"BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer","volume":"68","author":"Xia","year":"2008","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170511060840_RRT227C89","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511060840_RRT227C90","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature09727","article-title":"CREBBP mutations in relapsed acute lymphoblastic leukaemia","volume":"471","author":"Mullighan","year":"2011","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511060840_RRT227C91","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.2396","article-title":"Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer","volume":"44","author":"Peifer","year":"2012","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C92","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1158\/1078-0432.512.11.2","article-title":"Mutations and deletions of the CBP gene in human lung cancer","volume":"11","author":"Kishimoto","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170511060840_RRT227C93","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/73536","article-title":"Mutations truncating the Ep300 acetylase in human cancers","volume":"24","author":"Gayther","year":"2000","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C94","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-pathol-011811-132434","article-title":"The pathogenesis of mixed-lineage leukemia","volume":"7","author":"Muntean","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"key\n\t\t\t\t20170511060840_RRT227C95","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutation of EZH2 (Y641) in follicular and diffuse large B-cell lymphomas of germinal center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C96","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1073\/pnas.1116418109","article-title":"Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)","volume":"109","author":"McCabe","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170511060840_RRT227C97","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","article-title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders","volume":"42","author":"Ernst","year":"2010","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C98","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature08672","article-title":"Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes","volume":"463","author":"Dalgliesh","year":"2010","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511060840_RRT227C99","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ng.349","article-title":"Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer","volume":"41","author":"van Haaften","year":"2009","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170511060840_RRT227C100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrclinonc.2010.224","article-title":"Lung cancer in 2010: one size does not fit all","volume":"8","author":"Lovly","journal-title":"Nat Rev Clin Oncol 2011"},{"key":"key\n\t\t\t\t20170511060840_RRT227C101","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm.2658","article-title":"RET, ROS1 and ALK fusions in lung cancer","volume":"18","author":"Takeuchi","year":"2012","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170511060840_RRT227C102","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nm.2673","article-title":"Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies","volume":"18","author":"Lipson","year":"2012","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170511060840_RRT227C103","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nm.2644","article-title":"KIF5B-RET fusions in lung adenocarcinoma","volume":"18","author":"Kohno","year":"2012","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170511060840_RRT227C104","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/cas.12275","article-title":"RET fusion gene: translation to personalized lung cancer therapy","volume":"104","author":"Kohno","year":"2013","journal-title":"Cancer Sci"},{"key":"key\n\t\t\t\t20170511060840_RRT227C105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrd3374","article-title":"Harnessing synthetic lethal interactions in anticancer drug discovery","volume":"10","author":"Chan","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t20170511060840_RRT227C106","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ccr.2011.06.009","article-title":"Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor","volume":"20","author":"Daigle","year":"2011","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20170511060840_RRT227C107","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2013-04-497644","article-title":"Potent inhibition of DOT1L as treatment of MLL-fusion leukemia","volume":"122","author":"Daigle","year":"2013","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170511060840_RRT227C108","doi-asserted-by":"crossref","first-page":"20980","DOI":"10.1073\/pnas.1012525107","article-title":"Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas","volume":"107","author":"Sneeringer","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170511060840_RRT227C109","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood-2010-11-321208","article-title":"Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation","volume":"117","author":"Yap","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170511060840_RRT227C110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511060840_RRT227C111","doi-asserted-by":"crossref","first-page":"21360","DOI":"10.1073\/pnas.1210371110","article-title":"Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation","volume":"109","author":"Qi","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170511060840_RRT227C112","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nchembio.1084","article-title":"A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells","volume":"8","author":"Knutson","year":"2012","journal-title":"Nat Chem Biol"},{"key":"key\n\t\t\t\t20170511060840_RRT227C113","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1073\/pnas.1202258109","article-title":"Polycomb repressive complex 2 is required for MLL-AF9 leukemia","volume":"109","author":"Neff","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170511060840_RRT227C114","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/onc.2012.110","article-title":"The polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia","volume":"32","author":"Shi","year":"2013","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170511060840_RRT227C115","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nchembio.1331","article-title":"Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer","volume":"9","author":"Kim","year":"2013","journal-title":"Nat Chem Biol"},{"key":"key\n\t\t\t\t20170511060840_RRT227C116","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrd2974","article-title":"Protein methyltransferases as a target class for drug discovery","volume":"8","author":"Copeland","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t20170511060840_RRT227C117","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJM199310283291807","article-title":"Clinical implications of the p53 tumor-suppressor gene","volume":"329","author":"Harris","year":"1993","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170511060840_RRT227C118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cgt.2008.69","article-title":"Recent advances in p53 research: an interdisciplinary perspective","volume":"16","author":"Olivier","year":"2009","journal-title":"Cancer Gene Ther"},{"key":"key\n\t\t\t\t20170511060840_RRT227C119","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/mt.2008.70","article-title":"Translation of targeted oncolytic virotherapeutics from the lab into the clinic, and back again: a high-value iterative loop","volume":"16","author":"Liu","year":"2008","journal-title":"Mol Ther"},{"key":"key\n\t\t\t\t20170511060840_RRT227C120","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase","volume":"434","author":"Bryant","year":"2005","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511060840_RRT227C121","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511060840_RRT227C122","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170511060840_RRT227C123","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature11331","article-title":"Passenger deletions generate therapeutic vulnerabilities in cancer","volume":"488","author":"Muller","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511060840_RRT227C124","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002394","article-title":"Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality","volume":"3","author":"Chan","year":"2011","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20170511060840_RRT227C125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ccr.2009.12.046","article-title":"DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1","volume":"17","author":"Martin","year":"2010","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20170511060840_RRT227C126","doi-asserted-by":"crossref","first-page":"7922","DOI":"10.1073\/pnas.1303800110","article-title":"Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2","volume":"110","author":"Knutson","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170511060840_RRT227C127","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.1093\/emboj\/17.23.6979","article-title":"Altered control of cellular proliferation in the absence of mammalian brahma (SNF2\u03b1)","volume":"17","author":"Reyes","year":"1998","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t20170511060840_RRT227C128","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/neuonc\/nos285","article-title":"Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells","volume":"15","author":"Alimova","year":"2013","journal-title":"Neuro Oncol"},{"key":"key\n\t\t\t\t20170511060840_RRT227C129","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4161\/cbt.8.5.8019","article-title":"The role of SMARCB1\/INI1 in development of rhabdoid tumor","volume":"8","author":"Roberts","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"key\n\t\t\t\t20170511060840_RRT227C130","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/nm.2251","article-title":"Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway","volume":"16","author":"Jagani","year":"2010","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170511060840_RRT227C131","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fonc.2012.00114","article-title":"Atypical teratoid rhabdoid tumor: current therapy and future directions","volume":"2","author":"Ginn","year":"2012","journal-title":"Front Oncol"},{"key":"key\n\t\t\t\t20170511060840_RRT227C132","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/nm1111-1325","article-title":"First drugs found to inhibit elusive cancer target","volume":"17","author":"Moyer","year":"2011","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170511060840_RRT227C133","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature10334","article-title":"RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia","volume":"478","author":"Zuber","year":"2011","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511060840_RRT227C134","doi-asserted-by":"crossref","first-page":"16669","DOI":"10.1073\/pnas.1108190108","article-title":"Targeting MYC dependence in cancer by inhibiting BET bromodomains","volume":"108","author":"Mertz","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170511060840_RRT227C135","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170511060840_RRT227C136","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10509","article-title":"Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia","volume":"478","author":"Dawson","year":"2011","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511060840_RRT227C137","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511060840_RRT227C138","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Lov\u00e9n","year":"2013","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170511060840_RRT227C139","article-title":"World Cancer Report 2008","author":"Boyle","year":"2008"},{"key":"key\n\t\t\t\t20170511060840_RRT227C140","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/ng.2353","article-title":"A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population","volume":"44","author":"Shiraishi","year":"2012","journal-title":"Nat Genet"}],"container-title":["Journal of Radiation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jrr\/article-pdf\/55\/4\/613\/11832079\/rrt227.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T06:23:30Z","timestamp":1716531810000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jrr\/article-lookup\/doi\/10.1093\/jrr\/rrt227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,11]]},"references-count":140,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,2,11]]},"published-print":{"date-parts":[[2014,7]]}},"URL":"https:\/\/doi.org\/10.1093\/jrr\/rrt227","relation":{},"ISSN":["1349-9157","0449-3060"],"issn-type":[{"value":"1349-9157","type":"electronic"},{"value":"0449-3060","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2,11]]}}}